Excited to share our new work in @Science Translational Med! A collaborative effort exploring RNAi for silencing HBV antigens and rebalancing immunity in chronic hepatitis B.
I hope you enjoy it! and we’re always open to discuss perspectives! :)
Cristian G Beccaria
Happy to share our latest review "Targeting HBV with RNA interference: Paths to cure"| Science Translational Medicine www.science.org/doi/10.1126/... written together with @cristianbeccaria.bsky.social, Lena Allweiss, Julie Lucifora, John Tavis, Adam Gehring and Maura Dandri
RNA-targeting therapies hold promise for contributing to HBV cure regimens, but challenges remain before that promise can be realized.
